...
首页> 外文期刊>Einstein (So Paulo) >Analysis of clinical pharmacist interventions in a tertiary teaching hospital in Brazil
【24h】

Analysis of clinical pharmacist interventions in a tertiary teaching hospital in Brazil

机译:巴西一家三级教学医院的临床药剂师干预措施分析

获取原文

摘要

OBJECTIVE: To analyze the clinical pharmacist interventions performed during the review of prescription orders of the Adult Intensive Care, Cardiologic Intensive Care, and Clinical Cardiology Units of a large tertiary teaching hospital in Brazil. METHODS: The analysis took place daily with the following parameters: dose, rate of administration, presentation and/or dosage form, presence of inappropriate/unnecessary drugs, necessity of additional medication, more proper alternative therapies, presence of relevant drug interactions, inconsistencies in prescription orders, physical-chemical incompatibilities/solution stability. From this evaluation, the drug therapy problems were classified, as well as the resulting clinical interventions. RESULTS: During the study, a total of 6,438 drug orders were assessed and 933 interventions were performed. The most prevalent drug therapy problems involved ranitidine (28.44%), enoxaparin (13.76%), and meropenem (8.26%). The acceptability of the interventions was 76.32%. The most common problem found was related to dose, representing 46.73% of the total. CONCLUSION: Our study showed that up to 14.6% of the prescriptions reviewed had some drug therapy problem and the pharmacist interventions have promoted positive changes in seven to ten of these prescriptions.
机译:目的:分析在巴西一家大型三级教学医院的成人重症监护室,心脏重症监护室和临床心脏科的处方药复审过程中执行的临床药剂师干预措施。方法:每天进行以下分析,包括以下参数:剂量,给药速率,呈递和/或剂型,是否存在不合适/不必要的药物,是否需要额外的药物,更合适的替代疗法,相关药物相互作用的存在,处方订单,物理化学不相容性/溶液稳定性。根据该评估,对药物治疗问题以及产生的临床干预措施进行了分类。结果:在研究期间,共评估了6,438份药物订单,并进行了933次干预。最普遍的药物治疗问题涉及雷尼替丁(28.44%),依诺肝素(13.76%)和美罗培南(8.26%)。干预措施的接受率为76.32%。发现的最常见问题与剂量有关,占总数的46.73%。结论:我们的研究表明,多达14.6%的处方处方存在某些药物治疗问题,并且药剂师的干预促进了其中7到10个处方的积极变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号